Cytek Biosciences, Inc.CTKBNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-24.1%
5Y CAGR-35.0%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-24.1%/yr
Annual compound
5Y CAGR
-35.0%/yr
Recent acceleration
Percentile
P0
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
6 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.91 | -23.7% |
| 2024 | 3.82 | -31.7% |
| 2023 | 5.60 | -16.1% |
| 2022 | 6.67 | -53.0% |
| 2021 | 14.21 | -43.4% |
| 2020 | 25.12 | -41.0% |
| 2019 | 42.58 | - |